EFFICACY AND SAFETY OF DABRAFENIB plus TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED LOW-GRADE GLIOMA (LGG)

被引：0
|
作者：
Wen, Patrick [1 ]
De Greve, Jacques [2 ]
Mason, Warren [3 ]
Hofheinz, Ralf-Dieter [4 ]
Dietrich, Sascha [5 ]
de Vos, Filip [6 ]
van den Bent, Martin [7 ]
Mookerjee, Bijoyesh [8 ]
Boran, Aislyn [9 ]
Burgess, Paul [10 ]
Rangwala, Fatima [8 ]
Gazzah, Anas [11 ]
机构：
[1] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
[2] Univ Hosp Brussels, Brussels, Belgium
[3] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[4] Univ Hosp Mannheim, Mannheim, Germany
[5] Heidelberg Univ, Heidelberg, Germany
[6] UMC Utrecht Canc Ctr, Utrecht, Netherlands
[7] Erasmus MC Canc Inst, Rotterdam, Netherlands
[8] Novartis Pharmaceut, Global Clin Program, E Hanover, NJ USA
[9] Novartis Pharmaceut, Oncol Precis Med, E Hanover, NJ USA
[10] Novartis Pharma AG, Oncol Global Dev Unit, Basel, Switzerland
[11] Gustave Roussy Canc Inst, Villejuif, France
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RARE-11
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [1] UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)
    Wen, Patrick
    Stein, Alexander
    van den Bent, Martin
    De Greve, Jacques
    Dietrich, Sascha
    De Vos, Filip
    von Bubnoff, Nikolas
    van Linde, Myra
    Lai, Albert
    Prager, Gerald
    Campone, Mario
    Fasolo, Angelica
    Lopez-Martin, Jose
    Kim, Tae Min
    Mason, Warren
    Hofheinz, Ralf-Dieter
    Blay, Jean-Yves
    Cho, Daniel
    Gazzah, Anas
    Gomez-Roca, Carlos
    Yachnin, Jeffrey
    Boran, Aislyn
    Burgess, Paul
    Palanichamy, Ilan
    Gasal, Eduard
    Subbiah, Vivek
    [J]. NEURO-ONCOLOGY, 2019, 21 : 19 - 19
  • [2] EFFICACY AND SAFETY OF DABRAFENIB plus TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG)
    Wen, Patrick
    Alexander, Stein
    Yung-Jue, Bang
    van den Bent, Martin
    Gazzah, Anas
    Dietrich, Sascha
    de Vos, Filip
    van Linde, Mayra
    Lai, Albert
    Chi, Andrew
    Prager, Gerald
    Campone, Mario
    von Bubnoff, Nikolas
    Fasolo, Angelica
    Lopez-Martin, Jose
    Mookerjee, Bijoyesh
    Boran, Aislyn
    Burgess, Paul
    Rangwala, Fatima
    Subbiah, Vivek
    [J]. NEURO-ONCOLOGY, 2018, 20 : 238 - 238
  • [3] Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG).
    Subbiah, Vivek
    Stein, Alexander
    van den Bent, Martin
    Wick, Antje
    de Vos, Filip Y.
    von Bubnoff, Nikolas
    van Linde, Myra E.
    Lai, Albert
    Prager, Gerald W.
    Campone, Mario
    Fasolo, Angelica
    Lopez-Martin, Jose A.
    Kim, Tae Min
    Hofheinz, Ralf-Dieter
    Blay, Jean-Yves
    Cho, Daniel C.
    Gazzah, Anas
    Pouessel, Damien
    Yachnin, Jeffrey
    Boran, Aislyn
    Burgess, Paul
    Ilankumaran, Palanichamy
    Gasal, Eduard
    Wen, Patrick Y.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [4] SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB plus TRAMETINIB (D plus T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG)
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher
    Geoerger, Birgit
    Aerts, Isabelle
    Hargrave, Darren
    Cohen, Kenneth J.
    Kilburn, Lindsay B.
    Upadhyaya, Santhosh A.
    Wetmore, Cynthia
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    [J]. NEURO-ONCOLOGY, 2020, 22 : 375 - 375
  • [5] Efficacy and safety of dabrafenib plus trametinib in patients with BRAF V600E-mutated biliary tract cancer and adenocarcinoma of the small intestine
    Wainberg, Z.
    Lassen, U.
    Elez, E.
    Italiano, A.
    Curigliano, G.
    DeBraud, F.
    Prager, G.
    Greil, R.
    Stein, A.
    Angelica, F.
    Schellens, J. H. M.
    Wen, P. Y.
    Boran, A. D.
    Mookerjee, B.
    Burgess, P.
    Rangwala, F.
    Subbiah, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 103 : E3 - E4
  • [6] Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)
    Kreitman, Robert J.
    Moreau, Philippe
    Hutchings, Martin
    Gazzah, Anas
    Blay, Jean-Yves
    Wainberg, Zev A.
    Stein, Alexander
    Dietrich, Sascha
    de Jonge, Maja J. A.
    Willenbacher, Wolfgang
    De Greve, Jacques
    Arons, Evgeny
    Ravandi, Farhad
    Rangwala, Fatima
    Burgess, Paul
    Mookerjee, Bijoyesh
    Subbiah, Vivek
    [J]. BLOOD, 2018, 132
  • [7] Combination therapy of dabrafenib plus trametinib in patients with BRAF V600E-mutated biliary tract cancer
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (05) : 506 - 507
  • [8] Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma
    Bouffet, Eric
    Geoerger, Birgit
    Moertel, Christopher
    Whitlock, James A.
    Aerts, Isabelle
    Hargrave, Darren
    Osterloh, Lisa
    Tan, Eugene
    Choi, Jeea
    Russo, Mark
    Fox, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 664 - +
  • [9] Dabrafenib plus trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma: Safety and efficacy results.
    Geoerger, Birgit
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher L.
    Hargrave, Darren R.
    Aerts, Isabelle
    Cohen, Kenneth J.
    Kilburn, Lindsay Baker
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E-mutated lung adenocarcinoma
    Ota, Takayo
    Okabayashi, Aya
    Fukuoka, Masahiro
    [J]. RESPIROLOGY CASE REPORTS, 2021, 9 (10):
12345